Subscribe to this collection to receive daily e-mail notification of new additions

Issue Date	Title	Author(s)
2012-09	Antidepressant-like activity of (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a), a novel 5-HT3 receptor antagonist: An investigation in behaviour-based rodent models of depression	Mahesh, R.
2013-07	Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats	Mahesh, R.
2013-12	Design, Synthesis and Evaluation of Antidepressant Activity of Novel 2-Methoxy 1, 8 Naphthyridine 3-Carboxamides as 5-HT3 Receptor Antagonists	Mahesh, R.
2013	Antidepressant-like effect of novel 5-HT3 receptor antagonist N-n-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): An approach using rodent behavioral antidepressant tests	Mahesh, R.
2014-11	Anxiolytic-like effects of alverine citrate in experimental mouse models of anxiety	Mahesh, R.
2014-06	Design, Synthesis, and Pharmacological Evaluation of Novel 2-(4-substituted piperazin-1-yl)1, 8 Naphthyridine 3-Carboxylic Acids as 5-HT3 Receptor Antagonists for the Management of Depression	Mahesh, R.
2014-10	QCM-4, a serotonergic type 3 receptor modulator attenuates depression co-morbid with obesity in mice: An approach based on behavioral and biochemical investigations	Mahesh, R.
2017-12	Molecular modifications by regulating cAMP signaling and oxidant-antioxidant defence mechanisms, produce antidepressant-like effect: A possible mechanism of etazolate aftermaths of impact accelerated traumatic brain injury in rat model	Mahesh, R.
2010-05	Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats	Mahesh, R.
2016-01	A novel 5HT3 antagonist 4i (N-(3-chloro-2-methylphenyl)quinoxalin-2- carboxamide) prevents diabetes-induced depressive phenotypes in mice: Modulation of serotonergic system	Mahesh, R.
2012-12	Antidepressant Potential of 5-HT3 Receptor Antagonist, N-n- propyl-3-ethoxyquinoxaline-2-carboxamide (6n)	Mahesh, R.
2014	Anti-anxiety effect of a novel 5-HT3 receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice	Mahesh, R.
2013-11	QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice	Mahesh, R.
2013-01	Anxiolytic-like effect of linezolid in experimental mouse models of anxiety	Mahesh, R.
2013-08	Antidepressant-like activity of 2-(4-phenylpiperazin-1-yl)-1, 8-naphthyridine-3-carboxylic acid (7a), a 5-HT3 receptor antagonist in behaviour based rodent models: Evidence for the involvement of serotonergic system	Mahesh, R.
2014-05	Effect of a Selective Cyclooxygenase Type 2 Inhibitor Celecoxib on Depression Associated with Obesity in Mice: An Approach Using Behavioral Tests	Mahesh, R.
2014-11	Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression	Mahesh, R.
2017-10	A novel class of Plasmodial ClpP protease inhibitors as potential antimalarial agents	Mahesh, R.
2004	Pharmacophore Based Synthesis of 3-Chloroquinoxaline-2-carboxamides as Serotonin3 (5-HT3) Receptor Antagonist	Mahesh, R.
2012-08	Antidepressant-like effect of etazolate, a cyclic nucleotide phosphodiesterase 4 inhibitor—an approach using rodent behavioral antidepressant tests battery	Mahesh, R.